863443-01-0Relevant articles and documents
HIV INTEGRASE INHIBITORS
-
, (2015/09/22)
The present invention features compounds that are HIV integrase inhibitors and therefore are useful in the inhibition of HIV replication, the prevention and/or treatment of infection by HIV, and in the treatment of AIDS and/or ARC.
A scaleable synthesis of methyl 3-amino-5-(4-fluorobenzyl)-2- pyridinecarboxylate
Boros, Eric E.,Burova, Svetlana A.,Erickson, Greg A.,Johns, Brian A.,Koble, Cecilia S.,Kurose, Noriyuki,Sharp, Matthew J.,Tabet, Elie A.,Thompson, James B.,Toczko, Matthew A.
, p. 899 - 902 (2012/12/30)
A scaleable synthesis of methyl 3-amino-5-(4-fluorobenzyl)-2- pyridinecarboxylate (1b), starting from 5-bromo-2-methoxypyridine (8) and 4-fluorobenzaldehyde (9), is described. Key steps in the process include lithium-bromine exchange of 8, addition of the
HIV INTEGRASE INHIBITORS
-
Page/Page column 36-37, (2008/06/13)
The present infention features compounds that are HIV integrase inhibitors and may be useful in the inhibition of HIV replication, the prevention and/or treatment of infection by HIV, and in the treatment of AIDS and/or ARC.
HIV INTEGRASE INHIBITORS
-
Page/Page column 36-37, (2010/11/26)
The present infention features compounds that are HIV integrase inhibitors and may be useful in the inhibition of HIV replication, the prevention and/or treatment of infection by HIV, and in the treatment of AIDS and/or ARC.